0001365618-14-000006.txt : 20141021
0001365618-14-000006.hdr.sgml : 20141021
20141021190224
ACCESSION NUMBER: 0001365618-14-000006
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141016
FILED AS OF DATE: 20141021
DATE AS OF CHANGE: 20141021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
FORMER COMPANY:
FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hove Anders D
CENTRAL INDEX KEY: 0001365618
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 141166548
MAIL ADDRESS:
STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2014-10-16
2014-10-20
0001411158
Anacor Pharmaceuticals, Inc.
ANAC
0001365618
Hove Anders D
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
1
0
0
0
2.00% Convertible Senior Notes due 2021
31.05
2014-10-16
4
A
0
8000000.00
8000000.00
A
2021-07-15
2021-10-15
Common Stock
257648
8000000.00
I
By Funds and LLC's
The Form 4 filed on October 20, 2014 contained the following errors: a typographical error in Table II, Box 1 changing Debentures to Senior Notes; a typographical error in Table II, Box 2 changing the conversion price to the actual conversion price of $31.05; a typographical error in Table II, Box 6 correcting the exercisable date to July 15, 2021; and a typographical error in Table II, Box 7 increasing the Number of Shares to 257,648.
Consists of a convertible promissory note in the amount of $2,029,000.00 held by Venrock Healthcare Capital Partners, L.P. ("VHCP"), a convertible promissory note in the amount of $371,000.00 held by VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), a convertible promissory note in the amount of $4,709,000.00 held by Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and a convertible promissory note in the amount of $891,000.00 held by VHCP Co-Investment Holdings II, LLC ("VHCP Co-Invest II").
VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. VHCP Management II, LLC ("VHCP Management II") is the general partner of VHCP II and the manager of VHCP Co-Invest II and may be deemed to beneficially own these shares. Dr. Hove is a managing member of VHCP Management and VHCP Management II and may be deemed to beneficially own these shares. Dr. Hove, VHCP Management and VHCP Management II expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.
/s/ Anders D. Hove
2014-10-21